Literature DB >> 16004848

Treatment of leukoaraiosis.

Gary L Schwartz1, Myriam Fornage, Thomas Mosley, Stephen T Turner.   

Abstract

Altered signal intensity in the subcortical white matter on magnetic resonance imaging of the brain, referred to as leukoaraiosis, is frequently observed on imaging studies in elderly persons and was previously considered a benign accompaniment of aging. However, recent studies have found a clear association between the presence of leukoaraiosis and an increased risk for stroke, cognitive decline, and dementia. Moreover, epidemiologic studies have shown an association of leukoaraiosis with age, and several risk factors that are amenable to treatment, including smoking, hypertension, diabetes, homocysteinemia, hyperlipidemia, and excess alcohol use. Although results from prospective trials are not available, current evidence suggests that vigorous treatment of cardiovascular disease risk factors may prevent the development or progression of leukoaraiosis and the attendant risks of stroke and dementia.

Entities:  

Year:  2005        PMID: 16004848     DOI: 10.1007/s11936-005-0045-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  33 in total

Review 1.  Epidemiology of dementia and Alzheimer's disease.

Authors:  H C Hendrie
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

2.  Leuko-araiosis: an ancient term for a new problem.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

3.  Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension.

Authors:  D Inzitari; G P Giordano; A L Ancona; G Pracucci; M Mascalchi; L Amaducci
Journal:  Stroke       Date:  1990-10       Impact factor: 7.914

4.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

5.  Predictors of brain morphology for the men of the NHLBI twin study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; J Garner; L Jack; D Carmelli
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease.

Authors:  Jonathan Y Streifler; Michael Eliasziw; Oscar R Benavente; Sonia Alamowitch; Allan J Fox; Vladimir Hachinski; Henry J M Barnett
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

8.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home.

Authors:  A Ylikoski; T Erkinjuntti; R Raininko; S Sarna; R Sulkava; R Tilvis
Journal:  Stroke       Date:  1995-07       Impact factor: 7.914

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  5 in total

1.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Authors:  Myriam Fornage; Thomas H Mosley; Clifford R Jack; Mariza de Andrade; Sharon L R Kardia; Eric Boerwinkle; Stephen T Turner
Journal:  Hum Genet       Date:  2006-09-22       Impact factor: 4.132

2.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 3.  Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death.

Authors:  Jun Young Choi; Byung Gon Kim
Journal:  Exp Neurobiol       Date:  2017-08-25       Impact factor: 3.261

Review 4.  Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis.

Authors:  Clive B Beggs
Journal:  BMC Med       Date:  2013-05-31       Impact factor: 8.775

5.  Apathy and Leukoaraiosis in Mild Cognitive Impairment and Alzheimer's Disease: Multicenter Diagnostic Criteria according to the Latest Studies.

Authors:  Carmen María Sarabia-Cobo; Victoria Pérez; Carmen Hermosilla; María José Nuñez; Pablo de Lorena
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.